Bausch & Lomb (BLCO) Income from Non-Controlling Interests (2021 - 2026)

Bausch & Lomb (BLCO) posted Income from Non-Controlling Interests of $1.0 million for Q1 2026, down 66.67% on a QoQ basis from $3.0 million in Q3 2025, and little changed year-over-year from $1.0 million in Q1 2025.

Bausch & Lomb (BLCO) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends

Bausch & Lomb's Income from Non-Controlling Interests history runs 6 years deep, the most recent figure standing at $1.0 million for Q1 2026.

  • Quarterly Income from Non-Controlling Interests changed 0.0% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (down 11.11% YoY) and the FY2025 annual result came in at $8.0 million, down 33.33% from the prior year.
  • Income from Non-Controlling Interests was $1.0 million for Q1 2026 at Bausch & Lomb, down from $3.0 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $4.0 million in Q3 2023 and bottomed at $1.0 million in Q4 2022.
  • A 5-year average of $2.6 million and a median of $3.0 million in 2022 frame the typical range for Income from Non-Controlling Interests.
  • Annual changes were most pronounced in 2023 — Income from Non-Controlling Interests surged 200.0% — and 2025, when it plunged 75.0%.
  • Bausch & Lomb's Income from Non-Controlling Interests stood at $1.0 million in 2022, then jumped by 200.0% to $3.0 million in 2023, then plunged by 66.67% to $1.0 million in 2024, then jumped by 200.0% to $3.0 million in 2025, then plunged by 66.67% to $1.0 million in 2026.
  • Business Quant data shows BLCO's Income from Non-Controlling Interests at $1.0 million in Q1 2026, $3.0 million in Q3 2025, and $4.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn -18.70 Mn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn -
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn -
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn 110.00 Mn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn -
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn -
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn -
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn -
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn -
10 Bausch & Lomb 5.79 Bn 5.51 Bn 973.00 Mn 1.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.00 Mn
Sep 30, 2025 3.00 Mn
Jun 30, 2025 4.00 Mn
Mar 31, 2025 1.00 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 4.00 Mn
Jun 30, 2024 3.00 Mn
Mar 31, 2024 4.00 Mn
Dec 31, 2023 3.00 Mn
Sep 30, 2023 4.00 Mn
Jun 30, 2023 3.00 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 1.00 Mn
Sep 30, 2022 3.00 Mn
Jun 30, 2022 2.00 Mn
Mar 31, 2022 3.00 Mn
Dec 31, 2021 3.00 Mn
Sep 30, 2021 3.00 Mn
Jun 30, 2021 2.00 Mn
Mar 31, 2021 3.00 Mn